This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Impact Investment, Catalytic Capital and Blended Finance
Khanna, Tarun; Nanda, Ramana; Roth, Benjamin N.; Trelstad, BrianCase HBS-321078-EKnowledge and CommunicationStarting at €8.20
-
HCL Technologies (A)
Hill, Linda A.; Khanna, Tarun; Stecker, Emily A.Case HBS-408004-EKnowledge and CommunicationThis case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details. When Vineet Nayar became president of HCL Technologies, a global IT services business, in April 2005, he knew the company needed drastic change. Since its founding as a hardware company in the 1970s, HCL had grown into an enter...Starting at €8.20
-
Genzyme's CSR Dilemma: How to Play its HAND
Bartlett, Christopher A.; Khanna, Tarun; Choudhury, PrithwirajCase HBS-910407-EKnowledge and CommunicationGenzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases, (e.g. malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should management decide to fund. But the bigger issue is how this program developed under the umbrella role Genzyme's corporate social responsibility fits into its global competitive strategy.Starting at €8.20